Denosumab and incidence of type 2 diabetes among adults with osteoporosis: population based cohort study

Abstract

In this population based study, denosumab use was associated with a lower risk of incident type 2 diabetes compared with oral bisphosphonate use in adults with osteoporosis. This study provides evidence at a population level that denosumab may have added benefits for glucose metabolism compared with oral bisphosphonates.